Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
FDG-PET used for management of cervical and ovarian cancer
June 9th, 2005
FDG-PET was used to manage cervical and ovarian cancer. In a recent article published in the journal Gynecologic Oncology, scientists in the United States conducted a study "to assess the diagnostic performance of Positron Emission Tomography using fluorodeoxyglucose (FDG-PET) in comparison to conventional imaging modalities in the assessment of patients with cervical and ovarian cancer. Studies published between 1966 and 2003 were identified using all OVID search of the MEDLINE database." "Two reviewers independently abstracted data regarding sensitivity and specificity of PET," explained L.J. Havrilesky and colleagues, Duke...
Source: Women's Health Weekly (2005-06-09)
|
